Current share price for AZN : 11,708.000p 6 (0.05%)+
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue) is an ASX-listed company and is held by a number of exchange traded funds (ETFs). It , cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
| LON Code | AZN |
| Industry/Sector | Drug Manufacturers - General |
| Market Cap (£M) | 18,159,498 |
| AZN Share Price | 11,708.000p |
| Day High | 11,746.000p |
| Day Low | 11,604.000p |
| Last Close | 11,702.000p |
| AZN Share Price Movement | 6.00p ( 0.05% ) |
Astrazeneca PLC (AZN) is held across 37 ETFs spanning strategies that include drug manufacturers - general exposure . Its weighting in those funds means performance can have an outsized influence - when AZN moves, funds like F100, XALG, XASG, DRUG and FRGG that hold it can move with it.
For more concentrated exposure, ETFs such as F100 (BetaShares FTSE 100 ETF) allocate about 8.5% to AZN , while the average exposure across all 37 ETFs that hold it is around 1.3% .
Last updated: ETF data and holdings as at 14 August 2026
How does holding Astrazeneca PLC (AZN) shares directly compare to ETFs that include it?
|
AZN Direct
|
F100
ASX |
XALG
ASX |
XASG
ASX |
DRUG
ASX |
FRGG
ASX |
|
|---|---|---|---|---|---|---|
| Holdings | 1 company | 179 holdings | 10 holdings | 10 holdings | 110 holdings | 30 holdings |
| AZN Weight | 100% | 8.5% | 4.8% | 4.8% | 3.9% | 3.4% |
| Diversification | Single Stock | Broad | Broad | Broad | Broad | Broad |
| Annual Cost | Brokerage only | 0.45% p.a. | 1.04% p.a. | 0.75% p.a. | 0.47% p.a. | 0.9% p.a. |
| Approx. Yield | - | 3.37% | 2.4% | 0.14% | 3.9% | 23.78% |
| Star Ratings | - |
Yields and costs are approximate. ETF yields reflect the fund's dividend distributions, not AZN's direct yield. Annual cost uses each ETF's MER.
How a $10,000 investment in Astrazeneca PLC (AZN) one week ago compares with ETFs that hold it.
| Security | Investment type | Current price | 7-day price movement | Dollar change | Value today |
|---|---|---|---|---|---|
| Astrazeneca PLC (AZN) | Direct share | 11,708.000p | -2.73% | -272.52p | 9,727.48p |
| BetaShares FTSE 100 ETF (F100) | Equity - Global | 15.410p | -0.58% | -58.06p | 9,941.94p |
| Alphinity Global Equity Fund (Managed Fund) (XALG) | Equity - Global Strategy | 10.450p | -0.10% | -9.56p | 9,990.44p |
| Alphinity Global Sustainable Equity Fund (Managed Fund) (XASG) | Equity - Global Strategy | 6.900p | 0% | 0.00p | 10,000.00p |
| Betashares Global Healthcare ETF - Currency Hedged (DRUG) | Equity - Global Sectors | 8.890p | 1.95% | +194.95p | 10,194.95p |
| Franklin Global Growth Fund (Managed Fund) (FRGG) | Equity - Global Strategy | 1.565p | 0.97% | +96.77p | 10,096.77p |
Assumes $10,000 invested 7 days ago. Figures are based on price movement only and exclude distributions, fees and brokerage.
37 ETFs hold Astrazeneca PLC (AZN).
| ETF | AZN Weight | MER | Yield |
|---|---|---|---|
| BetaShares FTSE 100 ETF (F100) | 8.5% | 0.45% | 3.37% |
| Alphinity Global Equity Fund (Managed Fund) (XALG) | 4.8% | 1.04% | 2.4% |
| Alphinity Global Sustainable Equity Fund (Managed Fund) (XASG) | 4.8% | 0.75% | 0.14% |
| Betashares Global Healthcare ETF - Currency Hedged (DRUG) | 3.9% | 0.47% | 3.9% |
| Franklin Global Growth Fund (Managed Fund) (FRGG) | 3.4% | 0.9% | 23.78% |
| Betashares Global Cash Flow Kings ETF (CFLO) | 2% | 0.4% | 2.94% |
| Vanguard FTSE Europe Shares ETF (VEQ) | 1.8% | 0.35% | 2.15% |
| iShares Europe ETF (IEU) | 1.7% | 0.59% | 8.3% |
| Schroder Global Equity Alpha Fund - Active ETF (ALPH) | 1.7% | 0.65% | 0.73% |
| WCM Quality Global Growth Fund (Managed Fund) (WCMQ) | 1.6% | 1.35% | 7.4% |
| Operating Revenue Per Share | Price to Operating revenue | Price to free cash flow | Earnings Yield | PE Ratio | Dividend Yield | Forward Dividend Yield | Forward Earnings Yield |
|---|---|---|---|---|---|---|---|
| 38.97p | 300.43p | 4,088.70p | 4.23% | 23.66 | 2.04 | 2.04 | 6.48 |
| Created Date | Changed Date | Event |
|---|---|---|
| n/a | n/a | n/a |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.